EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
39 hedge funds and large institutions have $15.5M invested in Evelo Biosciences, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
89% less capital invested
Capital invested by funds: $140M → $15.5M (-$125M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $21K
Holders
39
Holding in Top 10
1
Calls
–
Puts
$21K
Top Buyers
| 1 | +$57.9K | |
| 2 | +$29.4K | |
| 3 | +$24.3K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$20.8K |
| 5 |
VF
Virtu Financial
New York
|
+$18.8K |
Top Sellers
| 1 | -$487K | |
| 2 | -$179K | |
| 3 | -$145K | |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
-$99K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$84.8K |